Sign Up to like & get recommendations! 0
Published in 2020 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2019.21669
Abstract: This cohort study investigates the association of hypertrophic obstructive cardiomyopathy with outcomes following transcatheter aortic valve replacement. read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Clinical Cardiology"
DOI: 10.1002/clc.23341
Abstract: Although radiofrequency ablation is widely used in the treatment of arrhythmias, its role in septal reduction therapy of hypertrophic obstructive cardiomyopathy (HOCM) is unclear. This meta‐analysis aimed to assess the efficacy and safety of radiofrequency… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Clinical Cardiology"
DOI: 10.1002/clc.24217
Abstract: Radiofrequency ablation has been applied for the treatment of hypertrophic obstructive cardiomyopathy (HOCM). The two known procedures are percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) and endocardial radiofrequency septal ablation (ERSA). read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Esc Heart Failure"
DOI: 10.1002/ehf2.12178
Abstract: Both surgical myectomy and percutaneous transluminal septal myocardial ablation are effective treatments for drug‐refractory symptomatic hypertrophic obstructive cardiomyopathy (HOCM). However, in some cases, it is not easy to elucidate the abnormal structure of left ventricular… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "General Thoracic and Cardiovascular Surgery"
DOI: 10.1007/s11748-018-1042-7
Abstract: Hypertrophic obstructive cardiomyopathy in Libman–Sacks endocarditis is quite rare and the correct etiological relationship between them is unknown. Some changes may cause a secondary disorganization of the ordinary muscle structure, making a disarray pattern with… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2020.12.039
Abstract: INTRODUCTION Sex-related differences in diagnosis and treatment of hypertrophic obstructive cardiomyopathy (HOCM) are still unclear. Therefore, we analyzed baseline characteristics of symptomatic patients with indication for alcohol septal ablation (PTSMA) with respect to gender. METHODS… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.07.080
Abstract: BACKGROUND In patients with disabling symptoms caused by hypertrophic obstructive cardiomyopathy (HOCM), echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) could be a less invasive treatment option. OBJECTIVES This study aimed to investigate the safety and… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.08.2069
Abstract: Surgical myectomy (SM) and Alcohol septal ablation (ASA) are both considered acceptable treatments for Hypertrophic Obstructive Cardiomyopathy (HOCM). Many recent studies shed more light into the long-term outcomes for both procedure and hence we performed… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "JACC: Cardiovascular Interventions"
DOI: 10.1016/j.jcin.2019.01.206
Abstract: Alcohol septal ablation (ASA) produces a targeted infarction of the septum, thereby relieving the outflow obstruction in hypertrophic obstructive cardiomyopathy (HOCM). There are several changes in the left ventricle with the relief of outflow obstruction.… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)30891-x
Abstract: Approximately 1 in 5 patients with hypertrophic obstructive cardiomyopathy (HOCM) have atrial fibrillation (AF) and HOCM patients with AF are at increased risk of heart failure-exacerbation and hospitalization. However, it is still unclear if pulmonary… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Cardiology in the young"
DOI: 10.1017/s104795112400057x
Abstract: Hypertrophic cardiomyopathy is the second most common cardiomyopathy affecting children and adolescents and is the main cause of sudden death of young athletes. The natural prognosis of children with severe hypertrophic obstructive cardiomyopathy is not… read more here.